Lumpectomy Market By Product (Surgical Tools, Lumpectomy Systems) , By End User (Hospitals, Clinics, Ambulatory Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033

August 2024 | 290 pages | ID: L52EBBE14FA7EN
Allied Market Research

Abstracts

Lumpectomy Market Expected to Garner $3.2 Billion by 2033, Growing at a CAGR of 6.9%

Abstract: The global lumpectomy market is expected to grow primarily due to the rising prevalence of breast cancer along with the growing preference for breast-conserving surgeries worldwide. The North America region is predicted to witness profitable growth by 2033.

As per the report published by Research Dive, the global lumpectomy market was valued at $1.7 billion in 2023 and is expected to register a revenue of $3.2 billion by 2033 at a CAGR of 6.9% during the forecast period 2024-2033.

Dynamics of the Market

The increasing prevalence of breast cancer worldwide along with the rising preference for breast-conserving surgeries, and the growing demand for comprehensive post-surgery care like radiation therapy are expected to make the lumpectomy market a highly profitable one in the forecast period. Besides, the growing focus on personalized medicine is another factor predicted to drive the market growth in the coming future.

However, according to market analysts, the lack of awareness among both patients & healthcare professionals and high costs associated with lumpectomy procedures might restrain the growth of the market.

Advancements in surgical techniques and technologies is predicted to offer numerous growth opportunities for the lumpectomy market in the forecast period. Moreover, with increasing awareness campaigns and screening programs detecting more breast cancer cases, there exists a significant opportunity for companies to develop and market cutting-edge technologies in the lumpectomy field to meet evolving medical community needs.

Key Players of the Market

The major players of the lumpectomy market include Vector Surgical, ClearCut Medical, Novian Health, Inc., Dune Medical Devices, iCAD, Sanarus, Hologic, Inc., Hologic, Medtronic PLC, and ZEISS.

What the Report Covers

In addition to the details highlighted in this description, the comprehensive final report delves into essential market aspects. These encompass a market overview, SWOT analysis, market dynamics, Porter’s five forces analysis, segmentation (key trends, regional analysis, and forecast analysis), and company profiles (including company overview, product portfolio, operating segments, strategic initiatives, and financial performance).

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Investment Opportunities
• Product Benchmarking / Product specification and applications
• Technology Trend Analysis
• Consumer Preference and Product Specifications
• Market share analysis of players by products/segments
• New Product Development/ Product Matrix of Key Players
• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Criss-cross segment analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)
• Market share analysis of players at global/region/country level
• SWOT Analysis

Key Market Segments

By Product

• Surgical Tools
• Lumpectomy Systems

By End User

• Hospitals
• Clinics
• Ambulatory Surgical Centers

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• France
• Germany
• Italy
• Spain
• UK
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific
• LAMEA
• Brazil
• South Africa
• Saudi Arabia
• UAE
• Rest of LAMEA
• Key Market Players
• vector surgical
• Novian Health, Inc
• ClearCut Medical
• Dune Medical Devices
• Sanarus
• iCAD
• Hologic, Inc.
• Medtronic PLC
• Hologic
• Zeiss

Contents

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
  1.4.1. Primary Research
  1.4.2. Secondary Research
  1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
  3.2.1. Top Investment Pockets
  3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
  3.3.1. Bargaining Power of Suppliers
  3.3.2. Threat of New Entrants
  3.3.3. Threat of Substitutes
  3.3.4. Competitive Rivalry
  3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
  3.4.1. Drivers
  3.4.2. Restraints
  3.4.3. Opportunities

CHAPTER 4: LUMPECTOMY MARKET, BY PRODUCT

4.1. Market Overview
  4.1.1 Market Size and Forecast, By Product
4.2. Surgical Tools
  4.2.1. Key Market Trends, Growth Factors and Opportunities
  4.2.2. Market Size and Forecast, By Region
  4.2.3. Market Share Analysis, By Country
4.3. Lumpectomy Systems
  4.3.1. Key Market Trends, Growth Factors and Opportunities
  4.3.2. Market Size and Forecast, By Region
  4.3.3. Market Share Analysis, By Country

CHAPTER 5: LUMPECTOMY MARKET, BY END USER

5.1. Market Overview
  5.1.1 Market Size and Forecast, By End User
5.2. Hospitals
  5.2.1. Key Market Trends, Growth Factors and Opportunities
  5.2.2. Market Size and Forecast, By Region
  5.2.3. Market Share Analysis, By Country
5.3. Clinics
  5.3.1. Key Market Trends, Growth Factors and Opportunities
  5.3.2. Market Size and Forecast, By Region
  5.3.3. Market Share Analysis, By Country
5.4. Ambulatory Surgical Centers
  5.4.1. Key Market Trends, Growth Factors and Opportunities
  5.4.2. Market Size and Forecast, By Region
  5.4.3. Market Share Analysis, By Country

CHAPTER 6: LUMPECTOMY MARKET, BY REGION

6.1. Market Overview
  6.1.1 Market Size and Forecast, By Region
6.2. North America
  6.2.1. Key Market Trends and Opportunities
  6.2.2. Market Size and Forecast, By Product
  6.2.3. Market Size and Forecast, By End User
  6.2.4. Market Size and Forecast, By Country
  6.2.5. U.S. Lumpectomy Market
    6.2.5.1. Market Size and Forecast, By Product
    6.2.5.2. Market Size and Forecast, By End User
  6.2.6. Canada Lumpectomy Market
    6.2.6.1. Market Size and Forecast, By Product
    6.2.6.2. Market Size and Forecast, By End User
  6.2.7. Mexico Lumpectomy Market
    6.2.7.1. Market Size and Forecast, By Product
    6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
  6.3.1. Key Market Trends and Opportunities
  6.3.2. Market Size and Forecast, By Product
  6.3.3. Market Size and Forecast, By End User
  6.3.4. Market Size and Forecast, By Country
  6.3.5. France Lumpectomy Market
    6.3.5.1. Market Size and Forecast, By Product
    6.3.5.2. Market Size and Forecast, By End User
  6.3.6. Germany Lumpectomy Market
    6.3.6.1. Market Size and Forecast, By Product
    6.3.6.2. Market Size and Forecast, By End User
  6.3.7. Italy Lumpectomy Market
    6.3.7.1. Market Size and Forecast, By Product
    6.3.7.2. Market Size and Forecast, By End User
  6.3.8. Spain Lumpectomy Market
    6.3.8.1. Market Size and Forecast, By Product
    6.3.8.2. Market Size and Forecast, By End User
  6.3.9. UK Lumpectomy Market
    6.3.9.1. Market Size and Forecast, By Product
    6.3.9.2. Market Size and Forecast, By End User
  6.3.10. Rest Of Europe Lumpectomy Market
    6.3.10.1. Market Size and Forecast, By Product
    6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
  6.4.1. Key Market Trends and Opportunities
  6.4.2. Market Size and Forecast, By Product
  6.4.3. Market Size and Forecast, By End User
  6.4.4. Market Size and Forecast, By Country
  6.4.5. China Lumpectomy Market
    6.4.5.1. Market Size and Forecast, By Product
    6.4.5.2. Market Size and Forecast, By End User
  6.4.6. Japan Lumpectomy Market
    6.4.6.1. Market Size and Forecast, By Product
    6.4.6.2. Market Size and Forecast, By End User
  6.4.7. India Lumpectomy Market
    6.4.7.1. Market Size and Forecast, By Product
    6.4.7.2. Market Size and Forecast, By End User
  6.4.8. Australia Lumpectomy Market
    6.4.8.1. Market Size and Forecast, By Product
    6.4.8.2. Market Size and Forecast, By End User
  6.4.9. South Korea Lumpectomy Market
    6.4.9.1. Market Size and Forecast, By Product
    6.4.9.2. Market Size and Forecast, By End User
  6.4.10. Rest of Asia-Pacific Lumpectomy Market
    6.4.10.1. Market Size and Forecast, By Product
    6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
  6.5.1. Key Market Trends and Opportunities
  6.5.2. Market Size and Forecast, By Product
  6.5.3. Market Size and Forecast, By End User
  6.5.4. Market Size and Forecast, By Country
  6.5.5. Brazil Lumpectomy Market
    6.5.5.1. Market Size and Forecast, By Product
    6.5.5.2. Market Size and Forecast, By End User
  6.5.6. South Africa Lumpectomy Market
    6.5.6.1. Market Size and Forecast, By Product
    6.5.6.2. Market Size and Forecast, By End User
  6.5.7. Saudi Arabia Lumpectomy Market
    6.5.7.1. Market Size and Forecast, By Product
    6.5.7.2. Market Size and Forecast, By End User
  6.5.8. UAE Lumpectomy Market
    6.5.8.1. Market Size and Forecast, By Product
    6.5.8.2. Market Size and Forecast, By End User
  6.5.9. Rest of LAMEA Lumpectomy Market
    6.5.9.1. Market Size and Forecast, By Product
    6.5.9.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

8.1. Vector Surgical
  8.1.1. Company Overview
  8.1.2. Key Executives
  8.1.3. Company Snapshot
  8.1.4. Operating Business Segments
  8.1.5. Product Portfolio
  8.1.6. Business Performance
  8.1.7. Key Strategic Moves and Developments
8.2. Novian Health, Inc
  8.2.1. Company Overview
  8.2.2. Key Executives
  8.2.3. Company Snapshot
  8.2.4. Operating Business Segments
  8.2.5. Product Portfolio
  8.2.6. Business Performance
  8.2.7. Key Strategic Moves and Developments
8.3. ClearCut Medical
  8.3.1. Company Overview
  8.3.2. Key Executives
  8.3.3. Company Snapshot
  8.3.4. Operating Business Segments
  8.3.5. Product Portfolio
  8.3.6. Business Performance
  8.3.7. Key Strategic Moves and Developments
8.4. Dune Medical Devices
  8.4.1. Company Overview
  8.4.2. Key Executives
  8.4.3. Company Snapshot
  8.4.4. Operating Business Segments
  8.4.5. Product Portfolio
  8.4.6. Business Performance
  8.4.7. Key Strategic Moves and Developments
8.5. Sanarus
  8.5.1. Company Overview
  8.5.2. Key Executives
  8.5.3. Company Snapshot
  8.5.4. Operating Business Segments
  8.5.5. Product Portfolio
  8.5.6. Business Performance
  8.5.7. Key Strategic Moves and Developments
8.6. ICAD
  8.6.1. Company Overview
  8.6.2. Key Executives
  8.6.3. Company Snapshot
  8.6.4. Operating Business Segments
  8.6.5. Product Portfolio
  8.6.6. Business Performance
  8.6.7. Key Strategic Moves and Developments
8.7. Hologic, Inc.
  8.7.1. Company Overview
  8.7.2. Key Executives
  8.7.3. Company Snapshot
  8.7.4. Operating Business Segments
  8.7.5. Product Portfolio
  8.7.6. Business Performance
  8.7.7. Key Strategic Moves and Developments
8.8. Medtronic PLC
  8.8.1. Company Overview
  8.8.2. Key Executives
  8.8.3. Company Snapshot
  8.8.4. Operating Business Segments
  8.8.5. Product Portfolio
  8.8.6. Business Performance
  8.8.7. Key Strategic Moves and Developments
8.9. Hologic
  8.9.1. Company Overview
  8.9.2. Key Executives
  8.9.3. Company Snapshot
  8.9.4. Operating Business Segments
  8.9.5. Product Portfolio
  8.9.6. Business Performance
  8.9.7. Key Strategic Moves and Developments
8.10. Zeiss
  8.10.1. Company Overview
  8.10.2. Key Executives
  8.10.3. Company Snapshot
  8.10.4. Operating Business Segments
  8.10.5. Product Portfolio
  8.10.6. Business Performance
  8.10.7. Key Strategic Moves and Developments